Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely nicotinic acid 500 milligram/1 each prolonged-release oral tablet (clinical drug) | Has manufactured dose form | Prolonged-release oral tablet | true | Inferred relationship | Some | ||
Product containing precisely nicotinic acid 500 milligram/1 each prolonged-release oral tablet (clinical drug) | har nämnarvärde som visar styrka | ett | false | Inferred relationship | Some | 1 | |
Product containing precisely nicotinic acid 500 milligram/1 each prolonged-release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Nicotinic acid (substance) | true | Inferred relationship | Some | 1 | |
Product containing precisely nicotinic acid 500 milligram/1 each prolonged-release oral tablet (clinical drug) | har täljarvärde som visar styrka | 500 | false | Inferred relationship | Some | 1 | |
Product containing precisely nicotinic acid 500 milligram/1 each prolonged-release oral tablet (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Product containing precisely nicotinic acid 500 milligram/1 each prolonged-release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
Product containing precisely nicotinic acid 500 milligram/1 each prolonged-release oral tablet (clinical drug) | Has precise active ingredient | Nicotinic acid (substance) | true | Inferred relationship | Some | 1 | |
Product containing precisely nicotinic acid 500 milligram/1 each prolonged-release oral tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
Product containing precisely nicotinic acid 500 milligram/1 each prolonged-release oral tablet (clinical drug) | Is a | Nicotinic acid-containing product in oral dose form | false | Inferred relationship | Some | ||
Product containing precisely nicotinic acid 500 milligram/1 each prolonged-release oral tablet (clinical drug) | räkning av bas i aktiv ingrediens | ett | false | Inferred relationship | Some | ||
Product containing precisely nicotinic acid 500 milligram/1 each prolonged-release oral tablet (clinical drug) | Is a | Nicotinic acid only product in oral dose form | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets